1.Characteristics and related clinical factors of myocardial 68Ga-FAPI-04 uptake in patients treated with anti-tumor therapy
Xiaofeng YU ; Yaqian ZHOU ; Qianyun WU ; Yinyan ZHU ; Lian XU ; Lianghua LI ; Cheng WANG ; Jianjun LIU ; Yumei CHEN
Chinese Journal of Nuclear Medicine and Molecular Imaging 2024;44(11):650-654
Objective:To analyze the value of 68Ga-fibroblast activation protein inhibitor (FAPI)-04 PET/CT in the detection of myocardial injury in patients treated with anti-tumor therapy. Methods:A retrospective study was conducted on 164 patients who underwent 68Ga-FAPI-04 PET/CT to evaluate the efficacy of anti-tumor therapy in Renji Hospital, School of Medicine, Shanghai Jiao Tong University between August 2021 and March 2024. The patients were divided into 68Ga-FAPI-04-positive group ( n=63, 36 males, 27 females, age (66.7±9.6) years) and 68Ga-FAPI-04-negative group ( n=101, 42 males, 59 females, age (55.2±14.1) years) based on the uptake of left ventricular myocardium (LVM). Moreover, FAPI-04 uptake was analyzed based on different types and locations, and the corresponding SUV max differences were analyzed by Kruskal-Wallis rank sum test. The differences of SUV max between 68Ga-FAPI-04-positive group and 68Ga-FAPI-04-negative group were analyzed by Mann-Whitney U test. The clinical factors such as gender, age, body mass index (BMI), previous history of coronary heart disease, left ventricular ejection fraction (LVEF), smoking history, hypertension, diabetes, cancer types and immune checkpoint inhibitors (ICIs) treatment were collected, and their predictive values for LVM 68Ga-FAPI-04 uptake were investigated by the binary logistic regression analysis. Results:Fifty patients of the 68Ga-FAPI-04-positive group (79.4%, 50/63) showed focal uptake of LVM, 7 patients (11.1%, 7/63) showed multifocal myocardial uptake, and 6 patients (9.5%, 6/63) showed diffuse myocardial uptake. A total of 127 uptake lesions were found, and most of them were located in the septum (37.8%, 48/127). The SUV max of LVM in 68Ga-FAPI-04-positive group and 68Ga-FAPI-04-negative group were 4.00(3.10, 5.40) and 1.31(1.20, 1.40) respectively ( z=-10.82, P<0.001). Differences of the SUV max among focal uptake group, multifocal myocardial uptake group, and diffuse myocardial uptake group were not significantly different (4.00(3.00, 5.10) vs 7.60(3.60, 9.30) vs 3.95(3.05, 5.05); H=3.81, P=0.149). There is no statistically significant difference either in FAPI uptake among different sites of LVM ( H=1.51, P=0.825). Age, previous history of coronary heart disease, BMI, LVEF and ICIs treatment were independent predictive factors for positive 68Ga-FAPI-04 uptake in the LVM (odds ratio ( OR) values: 0.87-10.43, all P<0.05). Conclusion:68Ga-FAPI-04 PET/CT is a potential new imaging method for the visualization of myocardial injury in patients with anti-tumor therapy.
2.Analysis of the results of screening for carriers of monogenic genetic diseases in 604 couples of childbearing age
Qianyun LI ; Renhua WU ; Yuanyuan ZHANG ; Fang LIU ; Weisheng CHENG ; Jing YUAN
Acta Universitatis Medicinalis Anhui 2024;59(9):1653-1658
Objective To understand the carrying situation and common variation of pathogenic genes of single gene hereditary disease in childbearing age population in Anhui province,to explore the establishment of clinical application network and referral model of carrier screening in Anhui province,and to explore the application value of expansible carrier screening(expanded carrier screening,ECS)in clinic.Methods Samples were collected from 604 individuals of childbearing age,all exhibiting a normal phenotype and a family history of inherited dis-ease.These samples were obtained during the first trimester or early stages of pregnancy(≤13+6 weeks).Based on high-throughput sequencing and special PCR analysis techniques,pathogenic variants associated with 220 disea-ses were detected,and related genes were detected in the spouses of positive carriers.Results As of May 16,2023,604 tested samples had been collected,and 340 carriers of the target disease had been detected;The posi-tive rate of pathogenic variation detection was 56.29% ;A total of 499 pathogenic variants were detected,with each tested individual carrying 0-5 variants;216 cases,accounting for 35.76% ,carried a single gene recessive dis-ease pathogenic variation,which was the most common.There were 95 cases carrying two types of single gene re-cessive genetic disease pathogenic variation,accounting for 15.73% .As of now,302 couples have been reported,and a total of 7 high-risk couples have been found through screening,with a high-risk rate of 2.32% .There are a total of 5 pairs with autosomal recessive genetic pattern(both spouses carry the same pathogenic gene),and 2 pairs with X-linked genetic pattern(the female carries the X-linked pathogenic gene).Conclusion In this study,we obtained the overall carrier and clinical application of target diseases as well as the carrier rates of causative genes of common single-gene genetic diseases in 604 subjects who underwent ECS testing,which could provide scientific guidance for the establishment of a clinical application network and referral model for carrier screening in Anhui Province.
3.Chinese herbal medicines for treating ulcerative colitis via regulating gut microbiota-intestinal immunity axis.
Yifei YANG ; Yi WANG ; Long ZHAO ; Fang WANG ; Mingxing LI ; Qin WANG ; Haoming LUO ; Qianyun ZHAO ; Jiuping ZENG ; Yueshui ZHAO ; Fukuan DU ; Yu CHEN ; Jing SHEN ; Shulin WEI ; Zhangang XIAO ; Xu WU
Chinese Herbal Medicines 2023;15(2):181-200
Ulcerative colitis (UC) is one of types of inflammatory bowel disease with high recurrence. Recent studies have highlighted that microbial dysbiosis as well as abnormal gut immunity are crucial factors that initiate a series of inflammatory responses in the UC. Modulating the gut microbiota-intestinal immunity loop has been suggested as one of key strategies for relieving UC. Many Chinese herbal medicines including some of single herb, herbal formulas and the derived constituents have been reported with protective effect against UC through modulating gut microbiome and intestinal immunity. Some clinical trials have shown promising results. This review thus focused on the current knowledge on using Chinese herbal medicines for treating UC from the mechanism aspects of regulating intestinal homeostasis involving microbiota and gut immunity. The existing clinical trials are also summarized.
4.Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases
Jiuping ZENG ; Mingxing LI ; Qianyun ZHAO ; Meijuan CHEN ; Long ZHAO ; Shulin WEI ; Huan YANG ; Yueshui ZHAO ; Anqi WANG ; Jing SHEN ; Fukuan DU ; Yu CHEN ; Shuai DENG ; Fang WANG ; Zhuo ZHANG ; Zhi LI ; Tiangang WANG ; Shengpeng WANG ; Zhangang XIAO ; Xu WU
Journal of Pharmaceutical Analysis 2023;13(6):545-562
As a ligand-dependent transcription factor,retinoid-associated orphan receptor γt(RORyt)that controls T helper(Th)17 cell differentiation and interleukin(IL)-17 expression plays a critical role in the pro-gression of several inflammatory and autoimmune conditions.An emerging novel approach to the therapy of these diseases thus involves controlling the transcriptional capacity of RORyt to decrease Th17 cell development and IL-17 production.Several RORyt inhibitors including both antagonists and inverse agonists have been discovered to regulate the transcriptional activity of RORyt by binding to orthosteric-or allosteric-binding sites in the ligand-binding domain.Some of small-molecule inhibitors have entered clinical evaluations.Therefore,in current review,the role of RORyt in Th17 regulation and Th17-related inflammatory and autoimmune diseases was highlighted.Notably,the recently developed RORyt inhibitors were summarized,with an emphasis on their optimization from lead compounds,ef-ficacy,toxicity,mechanisms of action,and clinical trials.The limitations of current development in this area were also discussed to facilitate future research.
5.Obstructive sleep apnea in patients with ischemic stroke: mechanism, diagnosis, and treatment
Qianyun ZHANG ; Xuechun LIU ; Wenpei WU ; Zheng TAN ; Xiaoying MENG ; Juncang WU
International Journal of Cerebrovascular Diseases 2023;31(7):535-541
Ischemic stroke is the main cause of death and disability in adults, and its incidence is increasing year by year. Obstructive sleep apnea (OSA) is the most common type of sleep-disordered breathing, which can increase the risk of ischemic stroke and affect the outcomes of patients. There is an increasing amount of research on the relationship between OSA and ischemic stroke. This article reviews the bidirectional relationship between OSA and ischemic stroke, the mechanism of OSA causing ischemic stroke, and the diagnosis and treatment of OSA in patients with ischemic stroke.
6.Carotid plaque and ischemic stroke
Xiaoying MENG ; Zheng TAN ; Wenpei WU ; Qianyun ZHANG ; Juncang WU
International Journal of Cerebrovascular Diseases 2023;31(9):672-676
Carotid atherosclerosis is closely associated with ischemic stroke. Research shows that the rupture of vulnerable carotid plaque is an important reason for carotid atherosclerosis leading to thromboembolic events. Therefore, early identification of vulnerable carotid plaques is of great significance for the diagnosis, treatment, and prevention of ischemic stroke. This article reviews the pathophysiological features, imaging evaluation of carotid plaque and its relationship with ischemic stroke.
7.Impact of obstructive sleep apnea on outcome in patients with acute ischemic stroke
Qianyun ZHANG ; Xuechun LIU ; Juncang WU
International Journal of Cerebrovascular Diseases 2023;31(12):895-900
Objective:To investigate the impact of obstructive sleep apnea (OSA) on neurological function outcome in patients with acute ischemic stroke (AIS) at 90 days after onset.Methods:Patients with AIS admitted to Hefei Second People's Hospital from September 2022 to June 2023 were prospectively included. According to the modified Rankin Scale score at 90 days after onset, they were divided into a good outcome group (0-2) and a poor outcome group (>2). The demographic data, vascular risk factors, baseline laboratory tests, National Institutes of Health Stroke Scale (NIHSS) scores at admission, severity of obstructive sleep apnea (OSA), and apnea hypopnea index (AHI) were compared between the two groups. Multivariate logistic regression analysis was used to determine the independent risk factors for poor outcomes. Results:A total of 104 patients with AIS were enrolled, including 62 males (59.6%), with a median age of 65.5 years (interquartile range, 57.0-72.0 years). The median baseline NIHSS score was 3.00 (interquartile range, 2.00-4.00). The median AHI was 18.14/h (interquartile range, 11.34-27.88/h), 43 patients (41.35%) with no/mild OSA and 61 patients (58.65%) with moderate to severe OSA. Seventy-four patients (71.2%) had good outcome, and 30 patients (28.8%) had poor outcome. When introducing AHI as a categorical variable into the logistic regression model, the higher baseline NIHSS score (odds ratio [ OR] 3.041, 95% confidence interval [ CI] 1.797-5.145; P<0.001) and moderate to severe OSA ( OR 4.413, 95% CI 1.032-18.877; P=0.045) were independent risk factors for poor outcome; When introducing AHI as a continuous variable into the logistic regression model, higher baseline NIHSS score ( OR 3.176, 95% CI 1.844-5.472; P<0.001), age ( OR 1.093, 95% CI 1.014-1.177; P=0.020), and AHI ( OR 1.044, 95% CI 1.002-1.089; P=0.042) were independent risk factors for poor outcome. Conclusion:Moderate to severe OSA is an independent risk factor for poor functional outcome in patients with AIS at 90 days after onset, and a higher AHI indicates poor outcome in patients.
8.Applications of stable isotope metabolic flux analysis in tumor metabolic reprogramming
Qianyun WU ; Wenzhi JIA ; Yumei CHEN ; Jianjun LIU
Chinese Journal of Nuclear Medicine and Molecular Imaging 2022;42(9):563-567
Metabolic reprogramming is a hallmark of tumors. Tumors own unique metabolic patterns in different stages of their occurrence and development. The stable isotope metabolic flux analysis technology uses stable isotope to trace the metabolites in tumors and crystallize tumor metabolism network. Stable isotope metabolic flux analysis is a useful tool for studying tumor metabolism, which can determine the nutritional sources, find the metabolic liabilities, confirm the metabolic pattern of tumors, and discover new mechanisms of tumor metabolic reprogramming, thus providing theoretical bases for imaging, diagnosis, treatment and evaluation of tumor. This article reviews the applications of stable isotope flux analysis in tumor metabolic reprogramming.
9.The experience of young patients with systemic lupus erythematosus:a qualitative research
Yingdan CHEN ; Huiqin XI ; Qianyun WU ; Junwei JIANG ; Xiaoling YUAN
Chinese Journal of Practical Nursing 2018;34(8):568-572
Objective To explore the illness experience and perspectives of youth patients with systemic lupus erythematosus (SLE) in China. Methods The research was conducted following phenomenological approach of qualitative research. Twelve patients with SLE were selected through purposive sampling method.The interviewer conducted hour-long semi-structured interviews according to the proposed interview outline.Data were analyzed based on Colaizzi phenomenological research method. Results Three themes were identified, including emotional experience since illness, SLE related limitations, and perceived stigma. Conclusions There exists a dynamic variation in disease related experience of young SLE patients.Understanding the feelings of those patients can help eliminate the negative factors so as to provide effective nursing intervention for patients and improve the quality of young patients′life with long-term living.
10.Lateral decubitus intramedullary nailing for femoral subtrochanteric fractures
Dake TONG ; Qiang WEI ; Peizhao LIU ; Xuzhou DUAN ; Qianyun HE ; Kang LIU ; Sheng QIN ; Kaihang XU ; Xuelin WU ; Hao ZHANG ; Hao TANG ; Dilshat ; Fang JI
Chinese Journal of Orthopaedic Trauma 2018;20(7):634-638
Objective To investigate the efficacy of lateral decubitus intramedullary nailing for treatment of subtrochanteric fractures of the femur.Methods From January 2012 to December 2015,23 patients with simple femoral subtrochanteric fracture were treated at Department of Orthopedic Trauma,Changhai Hospital.They were 15 males and 8 females,aged from 19 to 77 years (average,48.3 years).According to the Seinsheimer classification,there were 6 cases of type ⅡB,8 cases of type ⅡC,6 cases of type Ⅲ A,and 3 cases of type ⅢB.Their injuries were caused by traffic accident in 10 cases,falling from a height in 5 cases,and sprain in 8 cases.All patients were treated by closed reduction and anterograde intrarnedullary nailing at lateral decubitus.Their operative time,bleeding volume,fluoroscopic frequency,fracture healing time,functional recovery and complications were recorded and analyzed.Results Their operative time ranged from 55 to 80 min,averaging 65.7 min;their bleeding volumes ranged from 240 to 420 mL,averaging 304.3 mL;their fluoroscopic frequency ranged from 30 to 60 times,averaging 42.7 times.This cohort was followed up for 12 to 28 months (average,17.9 months).Their fracture healing time ranged from 4 to 10 months,averaging 5.5 months.Nonunion occurred in one patient but was cured by secondary operation.The HSS evaluation at the final follow-ups showed 17 excellent cases and 6 good ones,yielding an excellent to good rate of 100%.All the wounds healed by the first intention.No infection,deep vein thrombosis or implant failure was observed.Conclusion As lateral decubitus intramedullary nailing can achieve satisfactory clinical efficacy for subtrochanteric fractures of the femur,the body position of lateral decubitus may be a good alternative.


Result Analysis
Print
Save
E-mail